The autotransfusion devices market size has grown strongly in recent years. It will grow from $1.26 billion in 2025 to $1.35 billion in 2026 at a compound annual growth rate (CAGR) of 7%. The growth in the historic period can be attributed to increasing volume of surgical procedures, rising concerns over blood supply shortages, growing awareness of transfusion-related risks, adoption of intraoperative blood recovery techniques, expansion of trauma care facilities.
The autotransfusion devices market size is expected to see strong growth in the next few years. It will grow to $1.8 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to increasing focus on cost-effective surgical care, rising adoption of minimally invasive surgeries, expansion of patient blood management programs, growing demand for automated autotransfusion devices, continuous innovation in disposable consumables. Major trends in the forecast period include increasing adoption of blood conservation technologies, rising use of autologous transfusion in surgeries, growing demand for advanced cell salvage systems, expansion of emergency autotransfusion applications, enhanced focus on patient blood management.
The anticipated rise in cardiovascular diseases (CVDs) is set to propel growth within the autotransfusion device market. CVDs encompass a spectrum of heart and blood vessel disorders, and autotransfusion devices play a crucial role in reducing reliance on allogeneic blood transfusions. These devices facilitate reinfusion of a patient's own blood, mitigating the risks associated with donor blood transfusions. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2023, cardiovascular disease claimed 919,032 lives, accounting for one in every three deaths. Coronary heart disease remained the most prevalent form of heart disease, and notably, about one in six deaths from cardiovascular diseases occurred among adults younger than 65 years.
The rising demand for blood conservation is expected to propel the growth of the autotransfusion devices market in the coming years. Blood conservation in surgical procedures involves minimizing or avoiding allogeneic blood transfusions during and after surgery to enhance patient outcomes and safeguard patient rights. Autotransfusion devices support surgical procedures by reducing blood loss and improving overall clinical outcomes. For example, according to a report published in June 2023 by the World Health Organization (WHO), a Switzerland-based intergovernmental organization, 73% of reporting countries, or 125 out of 171, had established a national blood policy. Additionally, 66% of reporting countries, or 113 out of 171, had specific legislation addressing the safety and quality of blood transfusions, including 79% of high-income countries, 63% of middle-income countries, and 39% of low-income countries. Consequently, the increasing emphasis on blood conservation is driving the growth of the autotransfusion devices market.
Leading companies in the autotransfusion devices market are concentrating on creating technologically advanced solutions, including next-generation intelligent control software designed to improve precision, efficiency, and patient outcomes during blood transfusions. This next-generation software utilizes sophisticated algorithms to optimize the recovery, processing, and reinfusion of blood in real time, thereby enhancing both efficiency and patient safety. For example, in March 2023, Haemonetics Corporation, a U.S.-based provider of blood and plasma supplies and services, announced that the Cell Saver Elite+ Autotransfusion System received clearance from the U.S. Food and Drug Administration (FDA). This next-generation software maximizes the recovery of red blood cells during surgical procedures where medium to high blood loss is anticipated. This innovative upgrade streamlines autotransfusion processes, minimizes unnecessary allogeneic transfusions, and ultimately leads to improved patient outcomes.
Major companies operating in the autotransfusion devices market are Haemonetics Corporation, Medtronic plc, LivaNova plc, Terumo Corporation, Fresenius SE & Co. KGaA, B. Braun Melsungen AG, Asahi Kasei Medical Co. Ltd., Getinge AB, Baxter International Inc., Nipro Corporation, Teleflex Incorporated, Stryker Corporation, Braile Biomédica, Redax S.p.A., Gen World Medical Devices Corporation, Beijing ZKSK Technology Co. Ltd., Beijing Jingjing Medical Equipment Co. Ltd., Brightwake Ltd., Dideco, Atrium Medical Technologies.
North America was the largest region in the autotransfusion devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global autotransfusion devices market during the forecast period. The regions covered in the autotransfusion devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the autotransfusion devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the autotransfusion devices market by increasing costs of imported pumps, sensors, filters, tubing sets, and electronic control units used in blood recovery systems. Hospitals in North America and Europe are most affected due to reliance on imported medical equipment, while Asia-Pacific faces cost pressure on manufacturing exports. These tariffs are increasing capital equipment costs and consumable prices. However, they are also supporting localized device assembly, regional sourcing of consumables, and domestic production of surgical blood management solutions.
The autotransfusion devices market research report is one of a series of new reports that provides autotransfusion devices market statistics, including autotransfusion devices industry global market size, regional shares, competitors with a autotransfusion devices market share, detailed autotransfusion devices market segments, market trends and opportunities, and any further data you may need to thrive in the autotransfusion devices industry. This autotransfusion devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Autotransfusion devices are tools utilized to collect and reintroduce a patient's own blood during medical procedures, reducing reliance on donated blood - a method known as autologous blood transfusion. This approach notably diminishes the necessity for allogeneic (from a separate donor) blood transfusions. These devices find widespread application in trauma care within emergency departments and surgical settings.
The primary components of autotransfusion devices encompass autotransfusion systems, consumables, and accompanying accessories. Autotransfusion systems encompass both medical devices and methodologies enabling patients to receive their own blood for transfusions, negating the need for external donor blood. They serve diverse medical applications such as cardiovascular, orthopedic, neurological, obstetrics, gynecology surgeries, among others, and cater to various end-users including hospitals, specialized clinics, and other medical facilities.
The autotransfusion devices market consists of sales of on-pump transfusion devices and off-pump transfusion devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The autotransfusion devices market size is expected to see strong growth in the next few years. It will grow to $1.8 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to increasing focus on cost-effective surgical care, rising adoption of minimally invasive surgeries, expansion of patient blood management programs, growing demand for automated autotransfusion devices, continuous innovation in disposable consumables. Major trends in the forecast period include increasing adoption of blood conservation technologies, rising use of autologous transfusion in surgeries, growing demand for advanced cell salvage systems, expansion of emergency autotransfusion applications, enhanced focus on patient blood management.
The anticipated rise in cardiovascular diseases (CVDs) is set to propel growth within the autotransfusion device market. CVDs encompass a spectrum of heart and blood vessel disorders, and autotransfusion devices play a crucial role in reducing reliance on allogeneic blood transfusions. These devices facilitate reinfusion of a patient's own blood, mitigating the risks associated with donor blood transfusions. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2023, cardiovascular disease claimed 919,032 lives, accounting for one in every three deaths. Coronary heart disease remained the most prevalent form of heart disease, and notably, about one in six deaths from cardiovascular diseases occurred among adults younger than 65 years.
The rising demand for blood conservation is expected to propel the growth of the autotransfusion devices market in the coming years. Blood conservation in surgical procedures involves minimizing or avoiding allogeneic blood transfusions during and after surgery to enhance patient outcomes and safeguard patient rights. Autotransfusion devices support surgical procedures by reducing blood loss and improving overall clinical outcomes. For example, according to a report published in June 2023 by the World Health Organization (WHO), a Switzerland-based intergovernmental organization, 73% of reporting countries, or 125 out of 171, had established a national blood policy. Additionally, 66% of reporting countries, or 113 out of 171, had specific legislation addressing the safety and quality of blood transfusions, including 79% of high-income countries, 63% of middle-income countries, and 39% of low-income countries. Consequently, the increasing emphasis on blood conservation is driving the growth of the autotransfusion devices market.
Leading companies in the autotransfusion devices market are concentrating on creating technologically advanced solutions, including next-generation intelligent control software designed to improve precision, efficiency, and patient outcomes during blood transfusions. This next-generation software utilizes sophisticated algorithms to optimize the recovery, processing, and reinfusion of blood in real time, thereby enhancing both efficiency and patient safety. For example, in March 2023, Haemonetics Corporation, a U.S.-based provider of blood and plasma supplies and services, announced that the Cell Saver Elite+ Autotransfusion System received clearance from the U.S. Food and Drug Administration (FDA). This next-generation software maximizes the recovery of red blood cells during surgical procedures where medium to high blood loss is anticipated. This innovative upgrade streamlines autotransfusion processes, minimizes unnecessary allogeneic transfusions, and ultimately leads to improved patient outcomes.
Major companies operating in the autotransfusion devices market are Haemonetics Corporation, Medtronic plc, LivaNova plc, Terumo Corporation, Fresenius SE & Co. KGaA, B. Braun Melsungen AG, Asahi Kasei Medical Co. Ltd., Getinge AB, Baxter International Inc., Nipro Corporation, Teleflex Incorporated, Stryker Corporation, Braile Biomédica, Redax S.p.A., Gen World Medical Devices Corporation, Beijing ZKSK Technology Co. Ltd., Beijing Jingjing Medical Equipment Co. Ltd., Brightwake Ltd., Dideco, Atrium Medical Technologies.
North America was the largest region in the autotransfusion devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global autotransfusion devices market during the forecast period. The regions covered in the autotransfusion devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the autotransfusion devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the autotransfusion devices market by increasing costs of imported pumps, sensors, filters, tubing sets, and electronic control units used in blood recovery systems. Hospitals in North America and Europe are most affected due to reliance on imported medical equipment, while Asia-Pacific faces cost pressure on manufacturing exports. These tariffs are increasing capital equipment costs and consumable prices. However, they are also supporting localized device assembly, regional sourcing of consumables, and domestic production of surgical blood management solutions.
The autotransfusion devices market research report is one of a series of new reports that provides autotransfusion devices market statistics, including autotransfusion devices industry global market size, regional shares, competitors with a autotransfusion devices market share, detailed autotransfusion devices market segments, market trends and opportunities, and any further data you may need to thrive in the autotransfusion devices industry. This autotransfusion devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Autotransfusion devices are tools utilized to collect and reintroduce a patient's own blood during medical procedures, reducing reliance on donated blood - a method known as autologous blood transfusion. This approach notably diminishes the necessity for allogeneic (from a separate donor) blood transfusions. These devices find widespread application in trauma care within emergency departments and surgical settings.
The primary components of autotransfusion devices encompass autotransfusion systems, consumables, and accompanying accessories. Autotransfusion systems encompass both medical devices and methodologies enabling patients to receive their own blood for transfusions, negating the need for external donor blood. They serve diverse medical applications such as cardiovascular, orthopedic, neurological, obstetrics, gynecology surgeries, among others, and cater to various end-users including hospitals, specialized clinics, and other medical facilities.
The autotransfusion devices market consists of sales of on-pump transfusion devices and off-pump transfusion devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Autotransfusion Devices Market Characteristics
3. Autotransfusion Devices Market Supply Chain Analysis
4. Global Autotransfusion Devices Market Trends and Strategies
5. Autotransfusion Devices Market Analysis of End Use Industries
7. Global Autotransfusion Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Autotransfusion Devices Total Addressable Market (TAM) Analysis for the Market
9. Autotransfusion Devices Market Segmentation
10. Autotransfusion Devices Market Regional and Country Analysis
11. Asia-Pacific Autotransfusion Devices Market
12. China Autotransfusion Devices Market
13. India Autotransfusion Devices Market
14. Japan Autotransfusion Devices Market
15. Australia Autotransfusion Devices Market
16. Indonesia Autotransfusion Devices Market
17. South Korea Autotransfusion Devices Market
18. Taiwan Autotransfusion Devices Market
19. South East Asia Autotransfusion Devices Market
20. Western Europe Autotransfusion Devices Market
21. UK Autotransfusion Devices Market
22. Germany Autotransfusion Devices Market
23. France Autotransfusion Devices Market
24. Italy Autotransfusion Devices Market
25. Spain Autotransfusion Devices Market
26. Eastern Europe Autotransfusion Devices Market
27. Russia Autotransfusion Devices Market
28. North America Autotransfusion Devices Market
29. USA Autotransfusion Devices Market
30. Canada Autotransfusion Devices Market
31. South America Autotransfusion Devices Market
32. Brazil Autotransfusion Devices Market
33. Middle East Autotransfusion Devices Market
34. Africa Autotransfusion Devices Market
36. Autotransfusion Devices Market Competitive Landscape and Company Profiles
37. Autotransfusion Devices Market Other Major and Innovative Companies
40. Autotransfusion Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Autotransfusion Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses autotransfusion devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for autotransfusion devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The autotransfusion devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Autotransfusion Systems; Consumables And Accessories2) By Application: Cardiovascular Surgeries; Orthopedic Surgeries; Neurological Surgeries; Other Applications
3) By End-Use: Hospitals; Trauma Centers & Emergency Departments; Other End Users
Subsegments:
1) By Autotransfusion Systems: Surgical Autotransfusion Systems; Emergency Autotransfusion Systems; Continuous Flow Autotransfusion Systems2) By Consumables And Accessories: Collection Reservoirs; Blood Filters; Tubing Sets; Pumps; Anticoagulants
Companies Mentioned: Haemonetics Corporation; Medtronic plc; LivaNova plc; Terumo Corporation; Fresenius SE & Co. KGaA; B. Braun Melsungen AG; Asahi Kasei Medical Co. Ltd.; Getinge AB; Baxter International Inc.; Nipro Corporation; Teleflex Incorporated; Stryker Corporation; Braile Biomédica; Redax S.p.A.; Gen World Medical Devices Corporation; Beijing ZKSK Technology Co. Ltd.; Beijing Jingjing Medical Equipment Co. Ltd.; Brightwake Ltd.; Dideco; Atrium Medical Technologies
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Autotransfusion Devices market report include:- Haemonetics Corporation
- Medtronic plc
- LivaNova plc
- Terumo Corporation
- Fresenius SE & Co. KGaA
- B. Braun Melsungen AG
- Asahi Kasei Medical Co. Ltd.
- Getinge AB
- Baxter International Inc.
- Nipro Corporation
- Teleflex Incorporated
- Stryker Corporation
- Braile Biomédica
- Redax S.p.A.
- Gen World Medical Devices Corporation
- Beijing ZKSK Technology Co. Ltd.
- Beijing Jingjing Medical Equipment Co. Ltd.
- Brightwake Ltd.
- Dideco
- Atrium Medical Technologies
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.35 Billion |
| Forecasted Market Value ( USD | $ 1.8 Billion |
| Compound Annual Growth Rate | 7.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
